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Hydrophobic residues outside the active site of
HIV-1 protease frequently mutate in patients
undergoing protease inhibitor therapy; how-
ever, the mechanism by which these mutations
confer drug resistance is not understood. From
analysis of molecular dynamics simulations, 19
core hydrophobic residues appear to facilitate
the conformational changes that occur in HIV-1
protease. The hydrophobic core residues slide
by each other, exchanging one hydrophobic
van der Waal contact for another, with little
energy penalty, while maintaining many struc-
turally important hydrogen bonds. Such hydro-
phobic sliding may represent a general mecha-
nism bywhich proteins undergo conformational
changes. Mutation of these residues in HIV-1
protease would alter the packing of the hydro-
phobic core, affecting the conformational flexi-
bility of the protease. Therefore these residues
impact the dynamic balance between process-
ing substrates and binding inhibitors, and thus
contribute to drug resistance.
INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) protease is
a symmetric homodimeric aspartyl protease that cleaves
a series of ten nonhomologous and asymmetric substrate
sites in the Gag and Gag-Pro-Pol polyproteins, allowing
the virus to mature and become infectious. In the liganded
conformation of HIV-1 protease, two flaps close over the
active site, thereby encompassing the ligand (Figure 1B).
A crystal structure of the unliganded protease (Spinelli
et al., 1991) shows the flaps of the enzyme extended yet
still touching each other at Ile50 (Figure 1A). However, this
conformation is possibly stabilized by a crystal contact
from a symmetry related molecule (Scott and Schiffer,
2000; Spinelli et al., 1991). While it is clear that these flaps
must separate for a substrate to access the active site, theStructure 15, 225–method by which the substrate gains access to the active
site remains unclear. Numerous studies have explored the
movement of the flap region (Bandyopadhyay and Meher,
2006; Collins et al., 1995; Freedberg et al., 2002; Harte
et al., 1992; Hornak et al., 2006; Ishima et al., 1999; Katoh
et al., 2003; Meagher and Carlson, 2005; Perryman et al.,
2004, 2006; Scott and Schiffer, 2000; Toth and Borics,
2006a, 2006b), but few have explored the role of domains
outside the active site and flap region in substrate binding
(Ishima et al., 2001b; Muzammil et al., 2003; Ohtaka et al.,
2003; Perryman et al., 2004, 2006; Rose et al., 1995; Zoete
et al., 2002). Many residues outside the active site and flap
region are often associated with drug resistance and
somehow have a role in ligand binding. This role may be
to facilitate the conformational changes that occur in
HIV-1 protease to allow ligand binding.
Each monomer of HIV-1 protease is made up of 99 res-
idues, 40 of which are hydrophobic (Figure 1). Some of
these hydrophobic residues line the active site of the pro-
tease making close van der Waal contacts with the ligand,
while others are in the flap region. A third category of res-
idues encompasses the hydrophobic core within each
monomer of the protease. Within the set of core residues
are seven isoleucines, whose side chains can adopt a
large number of conformations (Ishima et al., 2001a,
2001b). As these isoleucines change conformations, they
could initiate conformational changes in the protease
through interdependent exchanges of van der Waal con-
tacts. Many residues within the hydrophobic core are as-
sociated with drug resistance (Johnson et al., 2004; Rhee
et al., 2005). For example, Leu33Phe is a secondary muta-
tion for all other inhibitors except saquinavir and nelfinavir
(Johnson et al., 2005). Protein crystal structures show that
this residue is not in contact with either substrates or in-
hibitors but is packed deeply into the hydrophobic core
(Figure 1). Therefore its role in drug resistance is not obvi-
ous. The role of other such core residues in the develop-
ment of drug resistance is similarly unclear.
We hypothesize that the hydrophobic residues within
the core, such as Leu33, facilitate the large conformational
change between liganded and unliganded conformations
of the protease as one hydrophobic surface slides by an-
otherwith aminimal energetic expense. Throughananalysis233, February 2007 ª2007 Elsevier Ltd All rights reserved 225
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Hydrophobic Sliding in HIV-1 Proteaseof molecular-dynamics (MD) simulations, we found 19 res-
idues in the core region of HIV-1 protease that had limited
solvent accessibility throughout the simulation. Further
analysis of these MD simulations revealed that these hy-
drophobic core residues facilitate the opening of the ac-
tive site cavity to allow for substrate binding. Mutations
Figure 1. Conservation of Hydrophobic Residues
Only the hydrophobic residues in HIV-1 protease are displayed. Resi-
dues colored red are completely conserved, those colored blue only
mutate to other hydrophobic residues, and cyan-colored residuesmu-
tate to hydrophilic residues. Yellow circles are used to highlight Leu33.
(A) Unliganded crystal structure of HIV-1 protease (PDB code: 1HHP).
(B) Liganded crystal structure of protease (PDB code: 1F7A).226 Structure 15, 225–233, February 2007 ª2007 Elsevier Ltd Ain the core likely affect the dynamic properties of HIV-1
protease and potentially affect the ability of protease to
bind inhibitors and substrates. Therefore, mutations in
this region that preferentially affect inhibitor binding over
substrate binding may explain the role of these residues
in the development of drug resistance.
RESULTS
Obtaining an atomic view of the concerted movements of
a protein is not easily achievable by any experimental tech-
nique. Therefore, solvated molecular-dynamics simula-
tions were performed to observe the conformational flexi-
bility of HIV-1 protease under three different starting
conditions. Two simulations were started from the crystal
structure of a substrate complex of HIV-1 protease (PDB
code: 1F7A) (Prabu-Jeyabalan et al., 2000, 2002), one
with the substrate (MDSUB), and the other without the sub-
strate (MDNOSUB). These simulations were run for 5 ns and
appeared to have reached a localminimum. The other sim-
ulation, MD1HHP, was started from the unliganded crystal
structure (PDB code: 1HHP). This simulation was per-
formed for 9 ns. Though MDNOSUB and MD1HHP were
both started from unliganded structures, the protease in
MDNOSUB was in the closed conformation, while the prote-
ase in MD1HHP was in the semiopen conformation. While
MDNOSUB had slightly larger fluctuations in peripheral re-
gions of the protein relative to MDSUB, the flexibility of the
protease in MD1HHP was much greater than either of the
two simulations started from the substrate-bound coordi-
nates in the time period sampled (Figure 2). The closed
conformation without substrate (MDNOSUB) appears to be
an energetically favorable conformation and did not sub-
stantially rearrange in the timescale of this simulation. The
flap region in MD1HHP and the amino terminus of protease
inMDSUB had the largest fluctuations, consistentwithwhat
has been seen byNMR (Freedberg et al., 2002; Hong et al.,
2000; Ishima et al., 1999, 2001a; Todd et al., 2000). Based
on the correlation between MD1HHP, MDSUB, and NMR re-
sults, we concluded that the force field is reasonable, and
the conformations sampled in the MD1HHP are not likely anFigure 2. Relative Fluctuations of the Alpha-Carbon Atoms during 1–5 ns
The fluctuations of each structure relative to the starting coordinates were mapped onto a ribbon diagram of each structure with coordinates from the
simulations. The backbone is colored based on the degree of fluctuations. Residues colored blue had greater than 0.4 A˚ fluctuations, those colored
purple greater than 0.55 A˚ fluctuations, magenta 0.7 A˚, orange 0.85 A˚, and yellow greater than 1 A˚ fluctuations. (A) MDSUB. (B) MDNOSUB. (C) MD1HHP.ll rights reserved
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Hydrophobic Sliding in HIV-1 Proteaseartifact of the simulation. To further examine the significant
changes observed in MD1HHP, this simulation was contin-
ued for another 5 ns with the AMBER8 software package
(Figure 3). By examining the protease in two force fields,
we determined that the changes observed were not an ar-
tifact of the GROMOS simulation. Additionally, because
the two monomers that started in the same conformation
underwentdifferent conformational changes,wewereable
to examine two possible pathways for protease dynamics.
In order to determinewhatwas causing these changes, we
began a detailed analysis of atomic interactions in these
simulations.
Figure 3. Snapshots of HIV-1 Protease during the MD1HHP
Simulation
The catalytic aspartic acids are displayed and colored black. Residues
11–22 are colored magenta, 31–38 colored red, 39–57 colored blue,
and 58–78 colored cyan. 1–10, 22–24, 25–32, and 79–99 are colored
gray. (A) Starting coordinates. (B) After 9 ns in the GROMOS96 force
field. (C) After an additional 5 ns in the AMBER force field.Structure 15, 225–2Maintenance of Hydrogen Bonds Provides Structural
Stability
As a protein undergoes conformational changes, it might
be possible for one set of hydrogen bonds to be ex-
changed with another, or with solvent, with very little
energy cost to the protein, as long as the total number of
bonds remains constant. However, this is not what is ob-
served in the simulationswhere conserved hydrogenbonds
appeared to stabilize the secondary structure. Throughout
the MDSUB and MDNOSUB simulations, and the first 5 ns of
the MD1HHP simulation, any hydrogen bonds that existed
were tracked with geometrical considerations of distance
and angle between the donor and acceptor atoms over
time. In Figure 4, all the hydrogen bonds that were both
formed greater than 50% of the time between the first
and fifth nanoseconds of the trajectory and found in all
three simulations are shown. Despite the increased fluctu-
ations of the protease in MD1HHP, many hydrogen bonds
were still maintained, although for a slightly smaller per-
centage of the time than in the other simulations. Most
of these hydrogen bonds were among backbone atoms.
In fact, the bonds appeared to maintain the secondary
structure of the protease as the enzyme undergoes con-
formational changes.
In order to compare the simulations with experimentally
determined structural information, six crystal structures of
HIV-1 protease bound to substrates were examined for
side-chain hydrogen bonds that were conserved between
the structures (Prabu-Jeyabalan et al., 2000, 2002). Only
five side chains in each monomer maintained conserved
hydrogen bonds among these structures, and these same
side chains maintained hydrogen bonds in all three simu-
lations more than 50% of the time in both monomers.
These five residues, Asp/Asn25, Thr26, Thr31, Asn83, and
Asn88, are highly conserved among viral isolates. Only
Asn88 mutates 9% of the time, usually to aspartic acid
or serine, under the pressure of inhibitor therapy (Shafer
et al., 1999a). Two of the residues, the catalytic Asp25 and
Thr26 (which is involved in a ‘‘fireman’s grip’’ with itself on
the dimer interface), have been extensively studied by
other groups (States et al., 1982; Wallqvist et al., 1998).
The other three residues, Thr31, Asn83, and Asn88, form a
network of conserved side-chain hydrogen bonds that
effectively cap off the hydrophobic residues within the
core of each monomer from the solvent environment
(Figure 4D) and are likely essential to the structural integ-
rity of the protease.
Residues within the Hydrophobic Core
While many significant hydrogen bonds were maintained
throughout the simulations, the unliganded protease un-
dergoesaconsiderableconformational change inMD1HHP.
In order to determine the mechanism of this change, we
thoroughly examined all the interresidue contacts in the
MD1HHP simulation. The examination of this simulation
revealed that hydrophobic residues in the core of protease
exchange contacts with each other and that these ex-
changes may lead to the conformational changes ob-
served. To determine which residues comprised the33, February 2007 ª2007 Elsevier Ltd All rights reserved 227
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Hydrophobic Sliding in HIV-1 ProteaseFigure 4. Hydrogen Bonds Maintain the Structure of HIV-1 Protease
Hydrogen bonds are colored based on the percentage of time they existed. Bonds colored black existed for more than 80%of the time, those colored
green for more than 60% of the time, and yellow for more than 50% of the time. Nitrogen atoms are colored blue, and oxygen atoms are colored red.
Side chains involved in conserved hydrogen bonds are displayed and colored cyan. These include Thr26, Thr31, His69, Asn83, and Asn88. (A)
Liganded HIV-1 protease simulated with the substrate bound. The gray box represents the area displayed in part (D). (B) Liganded HIV-1 protease
simulated with the substrate removed. (C) Unliganded HIV-1 protease. (D) Hydrogen bonds involving residues Thr31, Asn83, and Asn88. The carbon
atoms in these residues are colored magenta. The residues of the hydrophobic core are also shown with van der Waal spheres.hydrophobic core, a detailed structural analysis was per-
formed at every 0.5 ns in the MD1HHP simulation to look
for residueswhose side chainswere buried for themajority
of the simulation. This analysis revealed nineteen hydro-
phobic residues with especially limited solvent accessibil-
ity. These residues, alongwith theirmutational frequencies
in patient sequences, are shown in Table 1. There are228 Structure 15, 225–233, February 2007 ª2007 Elsevier Ltd Aseven isoleucines in the core of eachmonomer. Isoleucine,
whose side chain has more possible conformations than
leucine or valine, appears to provide increased flexibility
to the monomer. As the isoleucine side chains rotated
through different conformations, they facilitated dramatic
changes in the hydrophobic core observed in these simu-
lations. Five of these isoleucines mutate in the patientTable 1. Frequency of Mutation of the Residues in the Hydrophobic Core among Untreated and Treated Patients
Position 5 11 13 15 22 24 33 36 38 62 64 66 75 77 85 89 90 93 97
Wild-type amino acid L V I I A L L M L I I I V V I L L I L
Untreated patients (%) 0 0 38 24 0 0 2 55 0 12 15 0 0 15 0 47 0 30 0
Treated patients (%) 0 0 27 23 0 5 6 43 0 26 21 1 0 26 3 18 31 36 0
Most frequent mutation - - V V - I F I - V V F - I V M M L -
Numbers are listed as the percentage of sequences that had another amino acid at this site. Those listed in underlined italics cause
drug resistance, those in italics contribute to drug resistance, and those in bold are invariant (Johnson et al., 2005; Rhee et al., 2005;
Shafer et al., 1999b).ll rights reserved
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Hydrophobic Sliding in HIV-1 ProteaseFigure 5. Stereo Images of the Hydrophobic Core during the MD1HHP Simulation
Residues 11–22 are colored magenta, 31–38 colored red, 39–57 colored blue, and 58–78 colored cyan. 1–10, 22–24, 25–32, and 79–99 are colored
gray. An arrow points to the position of Ile15. (A) Unliganded HIV-1 protease at the start of the simulation when both monomers are in the same con-
formation. The same image is shown above both columns. (B) Monomer A after 9 ns. (C) Monomer B after 9 ns. (D) Monomer A after 14 ns. (E) Mono-
mer B after 14 ns.population, regardless of inhibitor therapy (Table 1). How-
ever, theyonlymutate toother hydrophobic residues,most
frequently valine. This implies that maintaining hydropho-
bic interactions in this core is essential to HIV-1 protease
function. In order to examinewhy these hydrophobic inter-
actions are important, we examined the changes in the
hydrophobic core over time by using MD simulations.
Rearrangement Occurs within the Hydrophobic
Cores
The conformational changes of the protease in theMD1HHP
simulation included a variety of changes throughout the
protein. In order to aid in the analysis and description of
these movements, four loops were highlighted in different
colors in Figures 3 and 5. The flap region, which consists
of residues 39–57, was colored blue. This region is not
part of the hydrophobic core, though it is attached at either
end to loops involved in the core. Just before the flap re-
gion is a short loop comprising residues 31–38 (red). A
larger loop made up of residues 58–78 (cyan) stems from
the other end of the flap region. The last loop consists ofStructure 15, 225–residues 11–21 (magenta). The two monomers, which
were in the same conformation at the start of the simula-
tion, rearranged differently, indicating that more than one
physically reasonable conformation of the protease was
accessible. Within the first 9 ns, the flap region slid back
and the tips of each flap curled into each active site. This
coincided with a significant rearrangement of the hydro-
phobic core as the other three loops all dropped relative
to their starting positions (Figure 3B). Additional changes
were observed when the simulation was continued for an
additional 5 ns in the AMBER simulation package. By ex-
amining the changes in atomic interactions within each
monomer, we can determine how these conformational
changes within the protease occur.
To compare the differences in conformation between
monomers that occur during the simulation, it is easiest
to focus on changes relative to a single residue. Ile15 in
the magenta loop is highlighted in Figure 5, which uses
stereo images to illustrate the changes in each monomer
at 9 and 14 ns relative to the starting positions. In the
unliganded crystal structure, Ile15 made van der Waal233, February 2007 ª2007 Elsevier Ltd All rights reserved 229
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Hydrophobic Sliding in HIV-1 Proteasecontacts with Leu33,Met36, and Leu38 in the red loop and
Ile62, Ile64, and Val75 in the cyan loop (Figure 5A). After 9
ns of molecular dynamics, however, this was no longer the
case, and the two monomers adopt very different confor-
mations. In one monomer, residues Leu33 and Leu38 in
the red loop slid over Ile15, increasing the contact be-
tween Leu38 and Ile15 (Figure 5B). Simultaneously, the
cyan loop slid downward as Ile15 exchanged contacts
with Ile64 and Val75 for contacts with Ile62 and Val77.
The correlated movements between the residues in the
red and cyan loops, which are attached to either end of
the flap region, facilitate the movement of the flap region
from the active site (Figure 3B). While correlated move-
ments of the red and cyan loops occurred in the second
monomer, changes in the red loop revolved around Ile13
instead of Ile15. In the second monomer residues Leu33
and Leu38 packed around Ile13, which left Ile15 partially
solvated (Figure 5C). The contacts that were made
by Ile15 with the cyan loop were split between Ile13 and
Ile15 in this monomer. On one side of the cyan loop,
Ile13 gained the contacts lost by Ile15 with Val75. On the
other side of this loop, Ile15 maintained contact with
Ile62 and Ile64. In this way, the red and cyan loops facili-
tated the movement of the flap region from the active
site over the first 9 ns.
Additional changes in both monomers were observed
after continuing the simulation for 5 ns in another force
field. In the first monomer, the flap region appeared to
be moving back toward the active site. This change was
facilitated by the upward movement of the cyan loop as
Val75 slid over Ile15 (Figure 5D). In the second monomer,
Ile15 moved back into the hydrophobic core displacing
Ile13 as Leu38 slid over Ile15 (Figure 5E). The red and
cyan loops in this monomer moved together through the
direct contact between Leu38 and Ile62, pulling the flap
further from the active site. The movements of these resi-
dues as they alter side-chain conformations led to corre-
lated movements of the various loops in protease. These
changes are likely to be physically reasonable as they
are primarily rearrangements of the hydrophobic residues,
and there should be very little energetic penalty for ex-
changing one set of hydrophobic van der Waal contacts
for another.
DISCUSSION
HIV-1 protease undergoes a large conformational change
in order for substrates (or inhibitors) to access the active
site. While the mechanism by which the flaps come apart
has been widely examined, in this study, we have shown
that an extensive rearrangement of the core region may
facilitate conformational changes in protease. This rear-
rangement was not due to the exchange of interresidue
hydrogen bonds in the core. As shown in Figure 4, many
hydrogenbondswereconservedbetweenMD1HHPand the
less flexible simulations MDSUB and MDNOSUB. The back-
bone hydrogen bonds appeared to stabilize the structure,
while some of the side-chain hydrogen bonds protected
the hydrophobic core from the solvent (Figure 4D). Further230 Structure 15, 225–233, February 2007 ª2007 Elsevier Ltd Aexamination of the MD1HHP simulation revealed that the
mechanism of the observed conformational changes was
the exchange of van der Waal contacts within the hydro-
phobic core.
Nineteen residues from each monomer were found to
comprise the hydrophobic core. Seven of the nineteen
residues in the core are isoleucines (Table 1), which have
more possible conformations than other hydrophobic res-
idues such as phenylalanine. The rotation of these isoleu-
cines through various rotamers assists in the sliding of
these residues over one another. As demonstrated in Fig-
ures 3 and 5, the exchange of van der Waal contacts be-
tween residues in the hydrophobic core is correlated with
dynamic changes in the protease structure. Many side
chains within the hydrophobic core also have been shown
by NMR to have significant internal motions on the subna-
nosecond timescale (Ishima et al., 2001b).When any of the
residues within this core region mutate, they only mutate
to other hydrophobic residues (Figure 1). This implies that
maintaining these hydrophobic contacts is important
to the protease structure or function. Based on these ob-
servations, we propose that the conservation of hydro-
phobic residues is required for the hydrophobic sliding
that allows the conformational changes required for prote-
ase function.
Of the 19 residues in the hydrophobic core, six are invari-
ant (<1%mutation rate) among either treated or untreated
patients (Table 1) (Shafer et al., 1999a). Twoof these invari-
ant residues, Leu5 and Leu97, are at the structurally con-
served dimer interface, and the sensitivity of these resi-
dues to mutation has already been shown (Choudhury
et al., 2003; Loeb et al., 1989). The other four invariant res-
idues are Val11, Ala22, Leu38, and Val75. Val11 and Ala22
do not interact with each other or with any of the other in-
variant residues but are in constant contact with other
highly variable residues in the hydrophobic core. The re-
maining two invariant residues, Leu38 and Val75, are in
separate loops in the protease, but they were in contact
with each other throughout the simulation. However, their
positions relative to each other changed as the flap region
slides down the side of protease (Figures 3 and 5). The side
chains of these two residues also have been reported to be
highly dynamic by NMR (Ishima et al., 2001b). The contact
between Leu38 and Val75may be a necessary component
of the flapmovement asLeu38 slides overVal75 facilitating
the relative movement of the cyan and red loops. Facilitat-
ing this movement may explain why Leu38 and Val75 are
invariant.
Many other residues in the hydrophobic core, however,
are correlated with drug resistance (Table 1) (Johnson
et al., 2004; Rhee et al., 2005; Shafer et al., 1999a). One
such residue is Leu33. While Leu33 is still conserved in
98% of the untreated and 94% of the treated patient pop-
ulation (Table 1), the development of mutations at this site,
particularly Leu33Phe, appears to be related to the most
recent generation of protease inhibitors. Leu33 is packed
into the core of each monomer throughout the simulation
and interacts with many different residues (Figure 5). Mu-
tation to phenylalanine would alter the packing of the corell rights reserved
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side chain. Additionally, phenylalanine has different prop-
erties than leucine. The aromatic ring, while nonpolar, is
capable of forming hydrogen bonds. Therefore, this
change would likely affect the conformational flexibility
of the monomer both by altering the packing of the core
and by potentially forming hydrogen bonds with backbone
atoms. Interestingly, in sequences with Leu33Phe muta-
tions, additional residues within the hydrophobic core
have an increased frequency of mutation. These changes
include increases relative to the general population of
Ile13Val from 34% to 51%, Ile62Val from 16% to 48%,
and Val77Ile from 18% to 35%. While each of these muta-
tions is correlated with drug resistance, their role has not
previously been uncovered. However, the interactions of
these residues with each other in the hydrophobic core
may explain the potential interdependence of these muta-
tions. Based on the cooperativity of their movements and
their mutational frequencies, we hypothesize that the role
of these sites in drug resistance is tomodify the conforma-
tional flexibility of HIV-1 protease. Mutation at sites within
the core to other hydrophobic residues could affect the
conformational range of the protease and, therefore, the
ease by which the inhibitors or substrates can bind. This
could explain the role of these residues in either causing
or contributing to drug resistance.
Drug resistance in HIV-1 protease is one of the greatest
challenges in developing new inhibitors. UsingMD simula-
tions, this study elucidated the motion of 19 hydrophobic
residues outside the active site that form the hydrophobic
core. The extensive rearrangement of this core to facilitate
a conformational change has not been previously de-
scribed and is not easily observed experimentally. How-
ever, such a change could occur with minimal energetic
expense because the changes only involve the exchange
of hydrophobic interactions. The association between
protease and its substrate is a highly dynamic process.
Proteaseundergoes a large conformational change tobind
its substrate, cleave a peptide bond, and then release the
protein product. Ideally, the binding of inhibitors to the
protease should be less dynamic because the inhibitor
should stay bound to the protease for a longer period of
time than the substrate. Mutations that increase the flexi-
bility of HIV-1 protease may detrimentally impact inhibitor
binding by increasing the rate of dissociation between the
protease and the inhibitor. Additionally, mutations that al-
ter the conformational flexibility may affect the balance
between unliganded and liganded states of the protease,
thereby specifically detrimentally impacting the recogni-
tion of inhibitor over substrates. In order to fully under-
stand the role of these residues in drug resistance, we
must further examine their role in the dynamic conforma-
tional changes in HIV-1 protease.
More generally, the mechanism of hydrophobic sliding
probably represents a commonmechanism by which pro-
teins undergo conformational changes. Most proteins
have either hydrophobic cores or hydrophobic surfaces,
which are often explored to understand protein folding.
These hydrophobic regions likely also facilitate dramaticStructure 15, 225conformational changes, at a minimal energetic expense,
that are necessary for the protein function. Thus, this study
proposes both a novel mechanism for protein dynamics
and an explanation for the role of nonactive site mutations
in the development of drug resistance.
EXPERIMENTAL PROCEDURES
GROMOS Molecular Dynamics Simulation
Three separate MD simulations were run with the GROMOS96 (Scott
et al., 1999; van Gunsteren et al., 1996) simulation package, and the
43A1 force field with the SPC water model (Berendsen et al., 1987)
were used in all simulations. Bond lengths were constrained by using
the SHAKE algorithm (Ryckaert et al., 1977) with a relative geometric
tolerance of 104. A twin-range pairlist of 8 and 14 A˚ was employed
in the nonbonded force calculations that was updated every 10 fs. A
Poisson-Boltzmann reaction field (Tironi et al., 1995) correction term
was employed in the Coulomb interactions. Temperature was main-
tained at 300 K, and pressure was maintained at 1 atm by using the
Berendsen weak coupling approach (Berendsen et al., 1984). A time
step of 2 fs was employed in the leapfrog integration scheme (vanGun-
steren and Berendsen, 1977). In the first simulation, the crystal struc-
ture of 1HHP was solvated with 5843 water molecules in a truncated
octahedron periodic box (MD1HHP). The second and third MD simula-
tions were started from the crystal structure of 1F7A. First, the struc-
ture was solvatedwith 7,334waters in a truncated octahedron periodic
box (MDSUB). In a separate simulation, the substrate from this crystal
structure was removed and the protein was solvated with 7,381 waters
in a truncated octahedron periodic box (MDNOSUB). A steepest descent
minimization was performed with the protein atoms harmonically re-
strained to their positions in the starting crystal structure. Initial atom
velocities corresponding to a temperature of 300 K were generated
from aMaxwellian distribution for an equilibration molecular-dynamics
(MD) run of 10 ps, keeping the harmonic restraints in place. The system
was equilibrated for a further 500 ps without harmonic restraints. A
simulation of 5 ns was performed for data collection, with coordinates
and energies saved every 1 ps. The MD1HHP was carried out for
another 4 ns.
The first nanosecond of all three simulations was considered equil-
ibration time and was not included in the analysis. The backbone al-
pha-carbon fluctuations relative to the starting structure were calcu-
lated for all three simulations between 1–5 ns. By using the PROAHB
analysis tool within GROMOS96, the coordinates at each ps were
also examined to look for the presence of hydrogen bonds between
1–5 ns in all the simulations. A hydrogen bond was defined by a dis-
tance between the hydrogen and the acceptor atom of less than
2.5 A˚ and a donor-hydrogen-acceptor angle of greater than 135. The
percentage of time these hydrogen bonds existed were calculated
andmapped onto coordinates from the simulation. In order to determine
which residues were part of the hydrophobic core, coordinates at ev-
ery 0.5 ns throughout the entire MD1HHP simulation were examined for
hydrophobic residues with limited solvent accessibility. Hydrophobic
residues within the core region of the protease were inspected for lim-
ited solvent accessibility with the graphic modeling program MIDAS
(Ferrin et al., 1988). Hydrophobic residues not solvent-accessible for
the majority of the simulation were defined as part of the hydrophobic
core.
AMBER Molecular Dynamics Simulation
The 9 ns coordinates of the GROMOS simulation were used as the
starting structure for this simulation performed with the AMBER8 soft-
ware package (Case et al., 2005). These coordinates were stripped of
the solvent, and 200 cycles of restrained steepest descent energymin-
imization were performed, restraining the protease with a harmonic
force constant of 9.55 kcal mol1 A˚2. The protease was then solvated
with a TIP3P water box to allow for at least 8 A˚ of water on each face of
protease. The initial periodic box dimensions were 82.2 by 82.6 by–233, February 2007 ª2007 Elsevier Ltd All rights reserved 231
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Hydrophobic Sliding in HIV-1 Protease80.4 A˚3. Approximately 14,000 water molecules were added to each
system, and 1,000 cycles of steepest descent energy minimization
were performed, keeping the protease coordinates fixed. Equilib-
ration of the system continued with 5,000 steps of restrained MD
with a 9.55 kcal mol1 A˚2 force constant and constant temperature
(300 K) and pressure (1 atm). This equilibration was followed by
25,000 steps of unrestrained MD. The data collecting portion of the
simulation was performed at constant temperature and pressure for
5 ns with 1 fs time steps. Coordinates at every 0.5 ns were examined
for changes in hydrophobic contacts.
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